Institute enhances immunotherapy for difficult-to-treat brain tumours with gut microbiota
Advanced treatments, known as immunotherapies that activate T cells—our body’s immune cells—to eliminate cancer cells,…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
Turning ultrasound into medicine: Low-intensity ultrasound unlocks precision cancer treatment
Traditional chemotherapy often damages healthy tissues while attacking tumours, leading to severe side effects. While…
Myelodysplastic syndrome: new model to find treatments
Researchers working on an incurable blood cancer can now use a new lab model which…
New drug target for metastatic eye melanoma
New research has found a novel target with therapeutic potential for metastatic eye melanoma, an…
Aspirin a day keeps bowel cancer at bay
Taking a single, small dose of aspirin a day can prevent bowel cancer in people…
QBiotics reports 80% objective response rate in injected tumours in Stage I of Phase IIA soft tissue sarcoma trial
QBiotics Group Limited (QBiotics) announced final efficacy and safety results from the first stage of…
Improving the efficiency of glioblastoma immunotherapy with gut microbiota
Immunotherapies that activate T cells to eliminate cancer cells have shown limited efficacy as standalone…
Stopping pancreatic cancer spread using benzaldehyde
Cancer cells can multiply rapidly. The aggressive cancer cells undergo conversion from their tightly connected…
New insights on genetic damage of some chemotherapies could guide future treatments with less harmful side effects
For the first time, scientists have systematically studied the genetic effects of chemotherapy on healthy…
Adults who have survived childhood cancer are at increased risk of severe COVID-19
People who have survived cancer as children are at higher risk of developing severe COVID-19,…